Market Overview The U.S. electrophysiology mapping and ablation devices market is witnessing strong growth momentum, driven by rising atrial fibrillation prevalence, earlier rhythm control strategies, and rapid adoption of advanced mapping platforms. Valued at USD 9.53 billion in 2024, the market is projected to expand at a CAGR of 8.92% from 2025 to 2034, reaching USD...